Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol
.
2015 Sep:26 Suppl 5:v108-15.
doi: 10.1093/annonc/mdv201.
Authors
F d'Amore
1
,
P Gaulard
2
,
L Trümper
3
,
P Corradini
4
,
W-S Kim
5
,
L Specht
6
,
M Bjerregaard Pedersen
1
,
M Ladetto
7
;
ESMO Guidelines Committee
Collaborators
ESMO Guidelines Committee
:
Andrés Cervantes
,
George Pentheroudakis
,
Nicholas Pavlidis
,
Rolf A Stahel
,
Fatima Cardoso
,
Elzbieta Senkus-Konefka
,
Dirk Arnold
,
Alan Horwich
,
Cristiana Sessa
,
Nicoletta Colombo
,
Lisa Licitra
,
Christian Buske
,
Marco Ladetto
,
Solange Peters
,
Jean-Yves Blay
,
Ulrich Keilholz
,
Florian Strasser
,
Azza Adel Hassan
,
Jørn Herrstedt
,
Keith H McGregor
,
Claire Bramley
,
Jennifer Lamarre
,
Matthew Wallace
,
Aude Galli
,
Svetlana Jezdic
Affiliations
1
Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
2
Department of Pathology, Hôpital Henri Mondor, Créteil, France.
3
Department of Hematology and Oncology, Georg August University, Göttingen, Germany.
4
Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy.
5
Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Seoul, Korea.
6
Department of Oncology and Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
7
Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
PMID:
26314772
DOI:
10.1093/annonc/mdv201
No abstract available
Publication types
Practice Guideline
MeSH terms
Humans
Lymphoma, T-Cell, Peripheral* / diagnosis
Lymphoma, T-Cell, Peripheral* / pathology
Lymphoma, T-Cell, Peripheral* / therapy
Neoplasm Staging
Prognosis